AI review of test results for pulmonary hypertension
Part of Heart & circulation, Lungs & breathing clinical trials.
This trial uses an artificial intelligence tool to look at results from tests used to evaluate pulmonary hypertension. It may help doctors make sense of your past test results, especially heart and lung evaluation results.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be 18 years or older
- You have had a right heart catheterization (RHC)
- You had routine heart/lung tests like chest X-ray, ECG, and echocardiogram (ultrasound of the heart)
- Your test results from those visits must be complete enough for the study to analyze
- Your test results must be of good enough quality (not too blurred, missing, or corrupted)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses an AI tool to help doctors decide if you should be tested for pulmonary hypertension (high blood pressure in the lungs), which can be a complication of interstitial lung disease. If the tool suggests you might have it, you may get an echocardiogram (an ultrasound of the heart) and a right heart catheterization (a test to measure pressure in the heart) to find out for sure.
This trial tests if an artificial intelligence (AI) system can help find signs of pulmonary arterial hypertension (high blood pressure in the lungs) and related heart problems. You may help by taking part if you're already having an echocardiogram (heart ultrasound) at Imperial College NHS Trust.
This study uses heart imaging tests to better understand pulmonary arterial hypertension (PAH) and predict outcomes. It may help doctors tailor treatment for people with PAH.
This study uses artificial intelligence to find better ways to screen for pulmonary arterial hypertension (a type of high blood pressure in the lungs) in people with systemic sclerosis (scleroderma). The goal is to catch the condition earlier so treatment can start sooner.
This trial is testing a new AI-powered tool to help doctors better diagnose a specific type of heart failure called HFpEF, where the heart pumps normally but doesn't relax properly. It may help you if you have symptoms like shortness of breath or swelling and your heart ultrasound shows normal pumping ability.
This trial uses artificial intelligence to analyze heart ultrasound images and detect blocked arteries in people with suspected coronary artery disease. It aims to see if AI can accurately find problems without needing more invasive tests.
Hear when a new Pulmonary Hypertension trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.